Linked Life Data

7455099

Source:http://linkedlifedata.com/resource/pubmed/id/7455099

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1981-3-17
pubmed:abstractText
Two cases of neonatal bowel opacification secondary to oral and rectal administration of Kayexalate (sodium polystyrene sulfonate) are presented. Abdominal radiographs of both infants showed a faint, homogeneous increase in density within the bowel lumen. The properties of Kayexalate and its possible interactions with the gastrointestinal tract are discussed. Kayexalate administration should be included in the differential diagnosis of bowel opacification.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0033-8419
pubmed:author
pubmed:issnType
Print
pubmed:volume
138
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
63-4
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Kayexalate: a new cause of neonatal bowel opacification.
pubmed:publicationType
Journal Article, Case Reports